You are here : Home / Quarterly Results / GLENMARK PHARMACEUTICALS LTD

GLENMARK PHARMACEUTICALS Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 13-Nov-21 Details👇

GLENMARK PHARMACEUTICALS Quarterly Results

Consolidated Sep2021
UnAudited
Jun2021
UnAudited
Mar2021
UnAudited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
UnAudited
Mar2020
UnAudited
Dec2019
UnAudited
Revenues ₹3,147 Cr ₹2,965 Cr ₹2,860 Cr ₹2,787 Cr ₹2,952 Cr ₹2,345 Cr ₹2,767 Cr ₹2,736 Cr
Expenses ₹2,557 Cr ₹2,391 Cr ₹2,336 Cr ₹2,257 Cr ₹2,400 Cr ₹1,867 Cr ₹2,302 Cr ₹2,295 Cr
Operating Income ₹590 Cr ₹574 Cr ₹523 Cr ₹530 Cr ₹553 Cr ₹478 Cr ₹466 Cr ₹440 Cr
Other Income ₹-13 Cr ₹59 Cr ₹8 Cr ₹15 Cr ₹-32 Cr ₹59 Cr ₹44 Cr ₹33 Cr
Interest ₹69 Cr ₹76 Cr ₹83 Cr ₹95 Cr ₹81 Cr ₹94 Cr ₹98 Cr ₹96 Cr
Depreciation ₹123 Cr ₹113 Cr ₹111 Cr ₹115 Cr ₹104 Cr ₹113 Cr ₹126 Cr ₹106 Cr
Profit Before Tax ₹385 Cr ₹444 Cr ₹338 Cr ₹348 Cr ₹339 Cr ₹358 Cr ₹318 Cr ₹271 Cr
Profit After Tax ₹275 Cr ₹307 Cr ₹234 Cr ₹248 Cr ₹234 Cr ₹254 Cr ₹220 Cr ₹191 Cr
EPS ₹9.13 ₹10.86 ₹8.29 ₹8.80 ₹8.29 ₹9.00 ₹7.81 ₹6.76

Check out Industry Peers

Peers & Returns1W1M1Y
GLENMARK PHARMACEUTICALS -5% -4.7% -4.2%
SUN PHARMACEUTICAL INDUSTRIES -5.4% 1.9% 35.7%
DIVIS LABORATORIES -10.7% -9.1% 14.7%
DR REDDYS LABORATORIES -7% -6% -13.6%
CIPLA -1.2% -1.8% 5.4%
GLAND PHARMA -10.1% -15.1% 56%
PIRAMAL ENTERPRISES -8% -8.2% 58.9%
CADILA HEALTHCARE -6% -12.5% -15.5%
TORRENT PHARMACEUTICALS -2.5% 2% 14.9%

GLENMARK PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

6.16 %

Y-o-Y

6.60 %

Quarters Revenues % Change
Sep2021 ₹3,147 Cr
6.16
Jun2021 ₹2,965 Cr
3.67
Mar2021 ₹2,860 Cr
2.62
Dec2020 ₹2,787 Cr
-5.61
Sep2020 ₹2,952 Cr
25.92
Jun2020 ₹2,345 Cr
-15.27
Mar2020 ₹2,767 Cr
1.17
Dec2019 ₹2,736 Cr -

GLENMARK PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

2.89 %

Y-o-Y

6.76 %

Quarters Operating Profit % Change
Sep2021 ₹590 Cr
2.89
Jun2021 ₹574 Cr
9.58
Mar2021 ₹523 Cr
-1.25
Dec2020 ₹530 Cr
-4.11
Sep2020 ₹553 Cr
15.63
Jun2020 ₹478 Cr
2.66
Mar2020 ₹466 Cr
5.82
Dec2019 ₹440 Cr -
Operating Margins
Q-o-Q

-3.10 %

Y-o-Y

0.16 %

Quarters Operating Margin% % Change
Sep2021 18.75%
-3.10
Jun2021 19.35%
5.74
Mar2021 18.3%
-3.79
Dec2020 19.02%
1.60
Sep2020 18.72%
-8.19
Jun2020 20.39%
21.15
Mar2020 16.83%
4.60
Dec2019 16.09% -

GLENMARK PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-10.35 %

Y-o-Y

17.44 %

Quarters Profit After Tax % Change
Sep2021 ₹275 Cr
-10.35
Jun2021 ₹307 Cr
31.07
Mar2021 ₹234 Cr
-5.77
Dec2020 ₹248 Cr
6.06
Sep2020 ₹234 Cr
-7.89
Jun2020 ₹254 Cr
15.31
Mar2020 ₹220 Cr
15.44
Dec2019 ₹191 Cr -
PAT Margins
Q-o-Q

-15.57 %

Y-o-Y

10.09 %

Quarters PAT Margin(%) % Change
Sep2021 8.73 %
-15.57
Jun2021 10.34 %
26.41
Mar2021 8.18 %
-8.19
Dec2020 8.91 %
12.36
Sep2020 7.93 %
-26.78
Jun2020 10.83 %
36.06
Mar2020 7.96 %
14.04
Dec2019 6.98 % -

GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-15.93 %

Y-o-Y

10.13 %

Quarters EPS % Change
Sep2021 ₹9.13
-15.93
Jun2021 ₹10.86
31.00
Mar2021 ₹8.29
-5.80
Dec2020 ₹8.8
6.15
Sep2020 ₹8.29
-7.89
Jun2020 ₹9
15.24
Mar2020 ₹7.81
15.53
Dec2019 ₹6.76 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

GLENMARK PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE LARGE MIDCAP -6.6% -0.2% 21.9%
S&P BSE 250 LARGEMIDCAP -6.6% -0.3% 23.3%
S&P BSE 500 -6.8% -0.2% 24.9%
S&P BSE ALLCAP -6.8% -0.1% 26.1%
S&P BSE HEALTHCARE -6.8% -5.1% 10.7%
S&P BSE 150 MIDCAP -7.7% -1.4% 38.3%
S&P BSE 400 MIDSMALLCAP -7.9% -0.7% 42.3%
S&P BSE MIDSMALLCAP -8.1% -1% 43%
S&P BSE MID CAP -8.2% -2.6% 29.6%
NSE Indices1W1M1Y
NIFTY PHARMA -6.2% -4.7% 2.7%
NIFTY 200 -6.7% -0.3% 22.5%
NIFTY HEALTHCARE -6.7% -5.2% NA
NIFTY 500 -6.8% -0.3% 24.9%
NIFTY LARGE MIDCAP 250 -7.1% -1% 28.9%
NIFTY500 MULTICAP 50:25:25 -7.2% -0.3% 33%
NIFTY MIDCAP150 -7.9% -1.9% 37.5%
NIFTY MID SMALL400 -8% -1% 42.6%
NIFTY FREE MIDCAP 100 -8.3% -1.8% 36.9%
NIFTY MIDCAP 50 -9% -2.1% 31.5%

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z